{"status": "Ok", "redirect_url": "https://www.investor.jnj.com/investor-news/news-details/2026/Johnson--Johnsons-Phase-3-prostate-cancer-study-shows-ERLEADA-apalutamide-before-and-after-surgery-significantly-reduces-risk-of-metastasis-or-death-breaking-a-decades-long-treatment-paradigm/default.aspx", "message": "News view counter 769198 successfully enlarged"}